MENLO PARK, Calif. — January 27, 2026 — Leads & Copy — PacBio (NASDAQ: PACB) will hold its quarterly conference call to discuss its fourth quarter and full year 2025 financial results on Thursday, February 12, 2026, at 5:00 pm Eastern Time, the company announced today.
The call will be available via webcast on PacBio’s website.
The conference call is scheduled for Thursday, February 12, 2026, at 5:00 pm ET (2:00 pm PT).
Listeners can access the live webcast or replay at https://investor.pacificbiosciences.com/.
Those wishing to participate by phone can use the toll-free number 1-888-349-0136 or, for international callers, 1-412-317-0459.
PacBio (NASDAQ: PACB) designs, develops, and manufactures advanced sequencing solutions for scientists and clinical researchers. Its products and technologies, including HiFi long-read sequencing, address solutions across research applications including human germline sequencing, plant and animal sciences, infectious disease and microbiology, oncology, and other emerging applications.
PacBio products are for Research Use Only and not for use in diagnostic procedures.
Source: PacBio
